|
| Felix Behling | University Hospital Tubingen, Eberhard-Karls-University Tubingen |
| Felix Behling | Center for CNS Tumors, Comprehensive Cancer Center Tubingen-Stuttgart, University Hospital Tubingen, Eberhard-Karls-University Tubingen |
| Ghazaleh Tabatabai | University Hospital Tubingen, Eberhard-Karls-University Tubingen |
| Ghazaleh Tabatabai | University Hospital Tubingen, Eberhard-Karls-University Tubingen |
| Ghazaleh Tabatabai | University Hospital Tubingen, Eberhard-Karls-University Tubingen |
| Ghazaleh Tabatabai | Hertie Institute for Clinical Brain Research |
| Ghazaleh Tabatabai | Center for CNS Tumors, Comprehensive Cancer Center Tubingen-Stuttgart, University Hospital Tubingen, Eberhard-Karls-University Tubingen |
| Ghazaleh Tabatabai | |
| Marcos Tatagiba | University Hospital Tubingen, Eberhard-Karls-University Tubingen |
| Marcos Tatagiba | Center for CNS Tumors, Comprehensive Cancer Center Tubingen-Stuttgart, University Hospital Tubingen, Eberhard-Karls-University Tubingen |
| Marco Skardelly | University Hospital Tubingen, Eberhard-Karls-University Tubingen |
| Marco Skardelly | Center for CNS Tumors, Comprehensive Cancer Center Tubingen-Stuttgart, University Hospital Tubingen, Eberhard-Karls-University Tubingen |